2m 2m 2m 2m 2m 2m 2m
CIBUS-A (CBUS)
NASDAQ
$1.43+$0.04 (+2.81%)
Price as of Jun 03, 2026 7:56 PM EDT- $109.9MMarket Cap
- -50.36%1-Year Change
- BiotechnologyIndustry
CIBUS-A (CBUS)
$1.43+$0.04 (+2.81%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 7.3M +62.22% | 4.5M +147.66% | 1.8M +1,057.32% | 157,000 -99.40% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Gross Profit | 7.3M +62.22% | 4.5M +147.66% | 1.8M +1,057.32% | 157,000 +106.11% | |
Sales and Marketing Expense | 26.9M -12.64% | 30.8M +6.51% | 28.9M +163.48% | 11.0M -28.66% | |
Research and Development Expense | -44.2M -12.36% | -50.4M +19.03% | -42.4M +266.72% | -11.6M +1.92% | |
Depreciation and Amortization Expense | 5.9M -13.65% | 6.9M +46.15% | 4.7M +205.93% | 1.5M -34.39% | |
Total Operating Expenses | 101.2M -61.48% | 262.7M -18.10% | 320.7M +1,323.62% | 22.5M -15.82% | |
Operating Profit | -97.5M -62.26% | -258.4M -18.97% | -318.9M +1,325.49% | -22.4M -23.74% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -87,000 -93.85% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -87,000 -93.85% | |
Total Nonoperating Income and Expense | 400,000 -95.69% | 9.3M +2,447.09% | -395,000 -107.10% | 5.6M +29,194.74% | |
Income before Taxes | -132.2M -53.24% | -282.7M -16.28% | -337.6M +1,898.95% | -16.9M -42.15% | |
Income Taxes | 29,000 0.00% | 29,000 +825.00% | -4,000 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -127.1M -49.45% | -251.4M -6.07% | -267.6M +1,484.44% | -16.9M -42.15% | |
Net Income from Continuing Operations Applicable to Common | -132.2M -53.24% | -282.7M -16.28% | -337.6M +1,898.95% | -16.9M -42.15% | |
Basic EPS and Net Income | -2.78 -74.33% | -10.83 -58.27% | -25.95 +6,913.51% | -0.37 -52.56% | |
Diluted EPS and Net Income | -2.78 -74.33% | -10.83 -58.27% | -25.95 +6,913.51% | -0.37 -52.56% | |
Basic Weighted Average Shares | 45.8M +97.04% | 23.2M +125.14% | 10.3M -77.58% | 46.0M +22.74% | |
Diluted Weighted Average Shares | 45.8M +97.04% | 23.2M +125.14% | 10.3M -77.58% | 46.0M +22.74% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 9.9M -31.25% | 14.4M -55.86% | 32.7M +854.16% | 3.4M -75.21% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Cash and Cash Equivalents and Short-Term Investments | 9.9M -31.25% | 14.4M -55.86% | 32.7M +854.16% | 3.4M -75.21% | |
Total Current Assets | 12.1M -28.78% | 16.9M -51.89% | 35.2M +752.37% | 4.1M -72.78% | |
Accumulated Depreciation | 17.0M +26.07% | 13.5M +50.57% | 9.0M +52.75% | 5.9M -23.95% | |
Property and Plant and Equipment and Net | 6.3M -44.93% | 11.4M -27.49% | 15.8M +249.31% | 4.5M -79.22% | |
Total Long-Term Assets | 926,000 -33.19% | 1.4M -2.53% | 1.4M +800.00% | 158,000 -13.66% | |
Total Assets | 305.0M -12.86% | 350.1M -35.70% | 544.4M +2,328.13% | 22.4M -39.72% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 435,000 -0.23% | 436,000 -47.66% | 833,000 +376.00% | 175,000 +1.74% | |
Total Current Liabilities | 16.9M -15.19% | 19.9M -6.78% | 21.3M +1,182.97% | 1.7M -65.76% | |
Total Long-Term Debt | 93,000 -58.85% | 226,000 -57.84% | 536,000 N/A | N/A N/A | |
Total Long-Term Liabilities | 1.6M +6.34% | 1.5M -21.41% | 1.9M +2,264.56% | 79,000 -88.75% | |
Total Liabilities | 283.2M +12.28% | 252.2M +22.38% | 206.1M +1,257.10% | 15.2M -34.14% | |
Retained Earnings | -858.3M +17.38% | -731.2M +52.40% | -479.8M +126.15% | -212.2M +8.19% | |
Total Stockholders Equity | 21.8M -76.31% | 92.2M -68.60% | 293.5M +3,957.38% | 7.2M -48.82% | |
Total Shares Outstanding | 54.3M +94.44% | 27.9M +17.84% | 23.7M -51.46% | 48.8M +25.97% | |
Cash Flow | |||||
Cash from Operating Activities | -50.6M -12.84% | -58.0M +25.61% | -46.2M +138.64% | -19.4M +2.94% | |
Capital Expenditures | 578,000 -28.47% | 808,000 -81.30% | 4.3M +184.28% | 1.5M +205.84% | |
Cash from Investing Activities | -578,000 -28.47% | -808,000 -101.47% | 55.1M +3,722.37% | -1.5M -113.57% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 46.6M +14.90% | 40.6M +99.79% | 20.3M +103.42% | 10.0M +166.94% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | 100.00% +1,111.16% | |
Operating Margin | -1,336.01% -76.73% | -5,742.13% -67.28% | -17,549.97% +23.17% | -14,248.41% +12,523.53% | |
Return on Assets | -38.80% -30.98% | -56.21% -40.48% | -94.43% +66.64% | -56.67% -2.46% | |
Return on Equity | -222.98% +71.03% | -130.38% -26.75% | -178.00% +12.57% | -158.12% +38.11% | |
Revenue Growth | 62.22% -57.86% | 147.66% -86.03% | 1,057.32% +1,163.75% | -99.40% -1,209.87% | |
Current Ratio | 0.72 -16.02% | 0.85 -48.39% | 1.65 -33.57% | 2.49 -20.51% | |
Cash Ratio | 0.59 -18.94% | 0.73 -52.65% | 1.53 -25.63% | 2.06 -27.59% | |
Debt-to-Equity Ratio | 0.02 +236.11% | 0.007 +53.19% | 0.005 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.002 -10.53% | 0.002 -24.00% | 0.003 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow